To expand upon the interrelationship of these biomarkers, data from SLE patients with two consecutive visits were segregated for analyses by increasing or decreasing IFN score by at least 50% from the first to the second visit. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.